
Minimal-Contact Versus Standard Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Cost-Effectiveness Results of a Multisite Trial
Author(s) -
Laura Dunlap,
James Jaccard,
Jeffrey M. Lackner
Publication year - 2021
Publication title -
annals of behavioral medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.701
H-Index - 133
eISSN - 1532-4796
pISSN - 0883-6612
DOI - 10.1093/abm/kaaa119
Subject(s) - irritable bowel syndrome , medicine , cognitive behavioral therapy , cognitive therapy , cost effectiveness , cognition , physical therapy , psychiatry , risk analysis (engineering)
Irritable bowel syndrome (IBS) is a common, often disabling gastrointestinal (GI) disorder for which there is no satisfactory medical treatment but is responsive to cognitive behavior therapy (CBT).